Adc Therapeutics Sa (ADCT)

R&D Expense Growth

-12.63%

Quarterly · Period ending:

ADCT logo

ADCT R&D Expense Growth

Latest reported-12.63%
ADCT Quarterly R&D Growth (QoQ) (0.00% → -12.63%)
High-resolution chart · PNG

ADCT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Adc Therapeutics Sa R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-12.6327%
9.3104%
-32.1568%
-10.9239%
4.0169%
6.7414%
-16.6174%
33.7806%
-5.5955%
-15.15%
6.6456%
-9.2591%
-18.327%
-21.2546%
16.933%
-14.1356%
-0.8478%
15.2029%
15.4517%
-6.9006%
0.9216%
-19.3195%
50.9936%
23.9114%
-26.6431%
16.2733%
-0.3831%
40.3539%
-6.5533%
-19.9519%
0%
-3.2478%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.